MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 140 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,548,223 | -50.3% | 51,686 | -21.4% | 0.04% | -48.7% |
| Q2 2023 | $15,190,791 | -8.7% | 65,761 | -4.2% | 0.08% | -15.6% |
| Q1 2023 | $16,634,541 | -5.1% | 68,664 | +13.7% | 0.09% | -10.9% |
| Q4 2022 | $17,533,132 | +979.6% | 60,407 | +141.7% | 0.10% | +818.2% |
| Q3 2022 | $1,624,000 | +237.6% | 24,989 | +271.6% | 0.01% | +266.7% |
| Q2 2022 | $481,000 | +46.2% | 6,725 | +100.8% | 0.00% | +50.0% |
| Q1 2022 | $329,000 | -12.7% | 3,349 | -24.7% | 0.00% | 0.0% |
| Q4 2021 | $377,000 | +83.9% | 4,445 | +72.7% | 0.00% | +100.0% |
| Q3 2021 | $205,000 | -72.7% | 2,574 | -61.3% | 0.00% | -80.0% |
| Q4 2018 | $750,000 | -58.5% | 6,650 | -21.3% | 0.01% | -50.0% |
| Q3 2018 | $1,809,000 | – | 8,450 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 1,402,250 | $93,614,000 | 4.00% |
| Parkman Healthcare Partners LLC | 30,000 | $2,003,000 | 0.93% |
| ARMISTICE CAPITAL, LLC | 216,000 | $14,420,000 | 0.89% |
| Avoro Capital Advisors LLC | 349,000 | $23,299,000 | 0.79% |
| Rock Springs Capital Management LP | 250,000 | $16,690,000 | 0.69% |
| Capital Impact Advisors, LLC | 24,351 | $1,626,000 | 0.68% |
| Baker Brothers Advisors | 1,499,212 | $100,087,000 | 0.62% |
| EWG Elevate Inc. | 11,086 | $740,000 | 0.56% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $801,000 | 0.54% |
| DAFNA Capital Management LLC | 13,600 | $908,000 | 0.38% |